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Modulation of renal Na-Pi cotransport by hormones acting via genomic
mechanism and by metabolic factors. The renal Na-Pj cotransport is
subject to multiple regulatory inputs, such as endocrine, paracrine and
intracrine. Among lipophilic, long-acting hormones that act via genomic
mechanism, thyroid hormones, calcitriol, all-trans-retinoic acid stimulate,
whereas glucocorticoids and estradiol inhibit the rate of Na-Pi cotransport
across the brush border membrane of proximal tubules in vivo and/or
across apical membrane of renal epithelial cells in Vitro. Some findings
suggest that these hormones may also influence Na-Pi cotransporter by
modification of membrane microenvironment. It should be considered
that Na-Pi cotransport can be modulated by lipophilic hormones by
non-genomic signaling mechanisms such as sphingomyelin-ceramide path-
way, NAD-cyclic ADP-ribose-Ca2 pathway or by Ca2 influx. Recent
studies outline a basis for the putative intracrine signaling mechanisms
that utilize Ca2treleasing nucleotides, cyclic ADP-rihosc, and nicotinic
acid adenosine dinucleotide phosphate (NAADP), as novel second mes-
sengers for regulation of Na-Pi cotransport in response to changes of
intermediary metabolic processes: gluconeogenesis, pentose phosphate
pathway, polyamines and metabolism of fatty acids.
For maintenance of the total body phosphate (Pi) homeostasis
of Pi regulation of renal excretion is of fundamental importance.
It is established that the extent to which Pi filtered in glomeruli is
reclaimed by tubule reabsorption and how much is excreted in
urine is primarily determined by capacity of apical (luminal) Na-Pi
cotransport (Na-Pi-COT) a from lumen of proximal tubule across
microvillar brush border membrane (BBM) which in turn is key
factor in total transtubular flux of Pi [1, 2]. In view of these
considerations, it is not surprising that the capacity of Na-Pi-COT
in BBM is modulated by large number of diverse hormones,
autacoids, growth factors and cytokines, as well as by metabolic
factors.
Over the years, information on regulation of renal Na-Pi-COT
was gathered mainly from studies of ex vivo prepared BBM
vesicles (BBMV) and from studies of Na-Pi-COT in tubular cells
grown in primary culture or renal cell lines, which preserve
properties of proximal tubules to a different degree, and in which
Na-Pi-COT in apical membranes is homologous to that found in
tubular BBM. The studies cx VLVO and in Vitro are complementary,
but their inherent limitations ought to be considered. In studies of
Na-Pi-COT in BBM ex vivo from animals administered a hormone
or in an induced metabolic state, even with using standard
precautions, such as thyroparathyroidectomy (TPTX), the ques-
© 1996 by the International Society of Nephrology
tion of whether the effect of hormone on Na-Pi-COT is indirect or
is due to secondary stimuli cannot be settled with certainty. Renal
cell lines such as opossum kidney cells (OK cells) are not
completely homogenous, and many subelones have regulatory
systems which are absent in others [3]. OK cells also have a very
low activity of BBM enzymes, namely alkaline phosphatase and
y-glutamyl transferase, compared to freshly prepared proximal
tubules [4]. Further, OK cells have severely blunted gluconeogen-
esis, but have high glycolytic activity [4]. Therefore, discrepancies
between the two systems, namely in case of failure to find similar
regulatory response, makes generalizations pertaining to regula-
tions of Na-Pi-COT difficult.
Regulations of Na-Pi-COT can be categorized (with necessary
overlaps) into four types: (a) fast-onset endocrine regulation by
polypeptide hormones, such as archetypal parathyroid hormone
(PTH), which act by binding on receptors outside on the cell
membrane and via intracellular signaling systems, such as cAMP-
protein kinase A (PKA) and/or phosphatidyl inositol phospholi-
pase C pathway; (b) with respect of autocrine/paracrine regulations,
some fast-acting regulators are autacoids (dopamine, serotonin) and
intracellular signaling systems are similar that of peptide hormones
[5]. Longer-acting regulations by growth factors (EGF) or cytokines
(TGF-/3) employ various Ras protooncogens, protein phosphoryla-
tion cascades and/or protein kinase C (PKC) pathways, leading to
gene activation [6]; (c) long-acting endocrine regulation by lipophilic
hormones, steroids and other small lipophilic compounds, which
have slow onset of action and act primarily by genomic mecha-
nism, that is, via nuclear receptors as enhancers/silences of gene
expression; and (d) intracrine regulations, when changes in cell
intermediary metabolism via specific intracellular signaling path-
way(s) modulate Na-Pi-COT.
Long-acting endocrine regulation by lipophilic hormones,
acting via "genomic" mechanism
The common characteristics of this family of long-acting,
slow-onset responses include following: these hormones are ste-
roids or other small lipophilic molecules that are carried in
circulation bound with high affinity on specific plasma transfer
proteins; they cross freely plasma membrane and in cytoplasm or
in nucleus bind onto cognate dimeric protein-receptor (Fig. 1A).
In turn, hormone-receptor complex binds to the hormone respon-
sive element (HRE) of DNA to enhance or suppress activity of
promoter of a gene transcription (Fig. IA). From this family of
hormones, modulatory effect upon Na-Pi-COT was shown for
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Fig. 1. A. Simplified scheme of genomic action
of lipophilic hormones. Hormone (A) meets the
cognate nuclear receptor (C) in cytoplasm,
hormone-receptor complex (r) translncates to
nucleus and binds to hormone responsive
element (HRE) of DNA. In the case of
calcitriol, T3 and atRA these hormones enter
the cell and combine with cognate receptor
within nucleus. B. General scheme of nuclear
receptor for lipophilic hormones (modified
from [71).
Table 1. Actions of lipophilic hormones upon renal Na-Pi-cotransporter in apical membranes
Effect on Na-cotransports of Pi and other solutes
-
Evidence
Reported non-genomicNa-H
Hormone Phosphate L-proline D-glucosc antiport SO4 Others in vivo in vitro Other effects actions
Thyroid hormones
(T3, T4)
I 0 ¶ 0 0 citrate yes yes ¶ Nat-dependent binding
of ['4C]-PFA
(phosphonoformic acid)
I transport Ca2-ATPase
Glucocorticoids ' 1' 1' 1 ¶ NT 0 citrate yes yes ¶ fluidity, change in lipids 1' sphingomyelin (SM)-
(GCD) of BBM; GCD
counteracts T3 effect
ceramide pathway
Calcitriol [1,25-
(OH)2V3]
All-trans-retinoic
¶
1'
NT
I
0
NT
NT
0
NT
1'
NT
¶
yes yes ¶ fluidity and changes in
lipids of BBM
NT yes 1' cyclic ADP-ribose
¶ SM-ceramide pathway
¶ Ca2 influx by channels
transport Ca2-ATPase
acid (atRA) L-glutamic
acid
synthesis
Estradiol (E2) 0 0 NT 0 NT yes NT ¶ la-hydroxylation of NT
calcitriol
Symbols and abbreviations are: ¶ ¶, distinct effect; ¶, minor effect; 0, no effect found; NT, not tested or unknown.
glucocorticoids (GCD), thyroid hormones (T3, T4), calcitriol
(la,25-(OH)2-vitamin D3) and, most recently, also alI-trans-reti-
noic acid (atRA) and estradiol (E2) (Table 1).
The general structural pattern of "steroid-lipophilic hormone"
receptor superfamily (Fig. 1B) is a protein molecule of 400 to 800
amino acids, which contain three major domains: (a) the hor-
mone-binding domain close to C-terminal; (b) the DNA-binding
domain located roughly in central region; and (c) variable N-
terminal domain. Some hormones bind on cognate receptor in
cytoplasm, such as GCD and E2, while receptors for atRA, T3 and
calcitriol remain within the nucleus (Fig. 1A). The DNA-binding
domains binds on the hormone response elements (HRE) on
DNA and are highly homologous (Fig. 1B). Consensus sequences
of the HREs are direct or inverted repeats [7, 8]. Considerable
number of receptors of this type were found in various tissues with
use of technique of molecular cloning, but their cognate ligands-
hormones are not yet known—the "orphan receptors" [7, 91.One
may speculate that some of "orphan receptors" in tubular cells
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may be targets of yet unidentified lipophilic hormones that may
regulate Na-P-COT, such as putative hormone that causes adap-
tive up-regulation of Na-Pi-COT in chronic Pi-deprivation in vivo.
As a common feature, hormones hind on receptor at hormone-
receptor domain, and this interaction is conformationally trans-
mitted to DNA-binding domain and promotes its interaction with
HRE. Activated HRE acts as enhancer, or less frequently, silencer
of the promoter of the gene(s). With respect of plasma membrane
Na-cotransporters, in the most straightforward scenario, the
gene that is activated (or repressed) by a given hormone is the
gene coding for synthesis of Na-Pi-COT and expression of the
activated gene proceeds, through all processing transcriptional,
translational and posttranslational steps, until the new molecule
of Na-Pi-COT is translocated and inserted into apical membrane
[1, 2, 10]. However, it is likely that the signaling mechanism is
more complex. Na-Pi-COT activity can be, for example, regulated
indirectly by activity of enzymes involved in changing synthesis of
BBM components that define membrane microenvironment [11]
for Na-Pi-COTR and other Na '-cotransporters, such as mole-
cules of membrane lipids that determine membrane fluidity [11,
I 2].
Successful effort of Dr. H. Murer and his associates [10] to
clone, with use of DNA recombinant technology, Na-Pi-COT
systems from renal cortical tissue of several animal species as well
as human, and from renal cell lines, represents first step in
formidable task to unravel intracellular regulatory mechanisms by
which lipophilic hormones modulate Na-Pi-COT. When reviewing
the current phenomenological knowledge on modulatory effects
of hitherto studied lipophilic hormones (Table 1) upon Na-Pi-
COT, following several common features are noted.
All these hormones (Table 1) do change V but not Km for Pi
of Na-Pi-COT. The onset of action is slow and effect prolonged.
The response of Na-Pi-COT to lipophilic hormones is invariably
blocked by inhibitors of transcription (such as actinomycin,
Act.D) as well as by inhibitors of translation and protein synthesis
such as cycloheximide (CHX) or others, thereby causing blanket
inhibition of these processes in the cell. Lipophilic hormones do
elicit a multitude of regulatory changes in tissues and organs. It is
noteworthy that modulatory response of Na-Pi-COT is accompa-
nied by simultaneous changes in other Na-cotransporters in BBM,
and perhaps in many more than are presently known, since only a
few Na-cotransporters are usually examined along with Na-Pi-
COT (Table 1). It would be important to know whether regulatory
changes in several Na-cotransporters occur synchronously or at
different initial time periods. Such knowledge may serve as a
guideline in tracking the sequence of the biochemical regulatory
mechanisms. Some patterns of Na-cotransporter responses can be
mimicked in vitro by the addition of simple chemicals affecting
membrane fluidity, such as benzylalcohol [111. Such a consider-
ation suggests, indirectly, that some of Na-Pi-COT regulatory
responses can be due to alterations of membrane fluidity in
microdomains of BBM, perhaps without (or with) a change in the
number of Na-Pi-COT per membrane unit.
Thyroid hormones
Both L-thyroxin (T4) and 3,5,3-triiodothyronine (T3) stimulate
Na-Pi-COT both in vivo [11, 13, 16] and in vitro [14, 15]. Although
T3 is more potent than T4, it appears that T4 need not to be
converted by 5'-deiodination to T3 to produce the effect [13]. The
increased Na-dependent binding of [14C]-phosphonoformic acid
(PFA) suggests an increase in the number of Na-Pi-COT in BBM
[111; both the increase in Na-Pi-COT activity and Na-[14CI-PFA
binding were blocked by Act-D and CHX [11]. In BBM of
proximal tubules the other effects in response to T3 include a
decrease in Na-L-proline cotransport [13] without changes in
Nat-dependent cotransports of D-glucose [11, 14], citrate [11]
and SO4 [16]. Further, the alkaline phosphatase activity is de-
creased and the Na-H antiport is markedly increased [11]. How-
ever, it appears that the changes in Na-H antiport and alkaline
phosphatase activity all occur solely or predominantly in superfi-
cial cortical tubular cells, while a stimulatory effect upon the
Na-Pi-COT was seen in BBM from juxtamedullary zone [13].
Incubation of cultured renal cells with 1' increased Na-dependent
Pi uptake in a similar manner [14, 15]. The stimulatory effects of
T3 and Pi-deprivation are additive; fasting does not block T3
action [11], and glucocorticoids can prevent or counteract T3
stimulation [17]. T3 was reported to stimulate transport Ca2-
ATPase by non-genomic effect [18].
Glucocorticoids
Glucocorticoids (GCD) administered in vivo have a potent
inhibitory effect upon Na-Pi-COT both in intact and TPTX'd rats
[19]. Other BBM effects include simultaneous increase of Na-H
antiport [20], slight increase in Na-glucose [12, 18] and Na-L-
proline [12] cotransports, and decreased alkaline phosphatase
activity [181. Na-dependent Pi uptake by primary cultured renal
cells is also inhibited by GCD, but aldosterone had no effect [21].
The inhibitory effect of GCD upon Na-Pi-COT is seen in Pi-
deprived rats [19] even after severe long-term Pi deprivation [22];
GCD also suppresses stimulatory effect of T3, another hormone of
this family [17]. Recently, GCD were found to decrease fluidity
and lipid composition of BBM [121.
Calcitriol (l,25-(OH)2-V3
Unlike in intestinal BBM, the modulatory effect of calcitriol
upon Na-Pi-COT in renal BBM has been far more difficult to
document. Whereas other lipophilic hormones have been shown
to act in the high pharmacologic doses in the ambient state, effects
of calcitriol upon Na-Pi-COT have been demonstrated virtually
only on vitamin D-depleted cells. In renal cells isolated and
cultured from the kidneys of vitamin D-depleted birds, incubation
with calcitriol in vitro resulted in a dose-dependent increase of
Na-dependent Pi uptake and not other tested solutes [23]. The
Nat-dependent Pi uptake was increased in cells isolated from
kidneys of vitamin D-depleted birds after administration of cal-
citriol in vivo, but cells from vitamin D-replete birds showed no
increase in Na-Pi-COT in response to calcitriol [24]. A similar
stimulatory effect of calcitriol was also observed in OK-7A cells, a
subclone of one of OK cells [31. In OK-7A cells the stimulatory
effect of calcitriol was additive to the increase of Na-Pi-COT by Pi
deprivation, and this study [3] also suggests partial involvement of
PKC. Increase of Na-Pi-COT was also found in BBM from
vitamin-D depleted rats [25]. Some findings indicate an effect
upon lipid composition of BBM [25, 26].
Interestingly, calcitriol has been shown in non-renal cells to
stimulate, at the membrane level, generation of ceramide [27], a
second messenger in sphingomyelin (SM)-ceramide cycle signal-
ing pathway [27, 28]. Further, by acting on plasma membrane
calcitriol caused Ca2 influx into cells [29]. These two effects are
non-genomic in nature.
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Fig. 2. Metabolism of cyclic ADP-rihose (cADPR). In LLC-PK1 cells ADP-ribose cyclase is stimulated by atRA [31].
Retinoic acid
The stimulatory effect of the alI-trans-retinoic acid (atRA) upon
Na-Pi-COT was discovered recently in studies on OK cells [30].
Na-Pi-COT is stimulated by atRA dose-dependent way and the
effect is seen in the atRA concentrations (6 to 15 nM) found in
human or rat plasma. The increase in Na-Pi-COT elicited by atRA
and the increase elicited by Pi-deprivation are additive, on the
other hand, the stimulatory effect of T3 and atRA show no
additivity [30]. Simultaneously with stimulation of Na-Pi-COT,
atRA also increases Nat-gradient-coupled cotransports of L-
glutamate, SO4, and L-proline [30] (Table 1), all to about the
similar degree ( + 40%). Nevertheless, the atRA effect upon for
Na-cotransporters is not generalized; the Na-L-alanine uptake,
Na-H antiport, as well as (Na-K) ATPase activity showed no
difference [30]. An analogous stimulatory effect of atRA upon
Na-Pi-COT was also found in LLC-PK1 cell line [30].
Of considerable interest is the finding (Fig. 2) that in LLC-PK1
cells atRA increases also activity of ADP-ribose cyclase [31], an
enzyme which catalyzes synthesis of cyclic ADP-ribose (cADPR)
from 13-NAD [32]. As elaborated further, cADPR is recently
discovered cyclic nucleotide (Fig. 2) which triggers Ca2 release
through ryanodine receptor-channel (RYR) [32, 33]. As T3, atRA
was reported to influence (inhibit) the transport Ca2-ATPase in
plasma membrane, a non-genomic effect [34].
Estrogens
In view that mRNA coding for /3-estradiol (E2) receptor was
found in OK cells [351 as well as E2 receptors in rat proximal
tubules [36], we explored the effect of E2 upon Na-cotransporters
in BBM from kidneys from overectomized and TPTX'd rats. In
response to E2 administration the Na-Pi-COT decreased ( —
40%), whereas Na-cotransports of SO4, L-proline and D-glucose
showed no change [37].
Comments on cellular mechanisms by which lipophilic hormones
regulate Na-Pi-COT
It should be considered that genomic response to lipophilic
hormones can be modulated by interaction with transcription
factors that are activated by second messengers. An important
factor in regulation of gene expression is cAMP-responsive ele-
ment (CRE) and CRE-binding protein (CREB). CERB is acti-
vated by catalytic subunit of protein kinase A (PKA) but also by
phosphorylation with Ca2-calmodulin (CaM)-dependent protein
kinase on Ser'33 [38, 39].
Some other recently identified second messengers may also act
via analogous mechanisms. Incubation of cells with atRA stimu-
lates accumulation of cADPR [31], which can conceivably activate
CREB via release of Ca2 and activation of Ca2-CaM protein
kinase. It can be also speculated that cADPR may influence
genomic regulation of Na-Pi-COT by atRA and/or have a direct,
non-genomic effect. With respect of calcitriol, and also possibly
GCD [27], it should be recalled that this hormone can trigger
sphingomyelin (SM)-ceramide signaling pathway in which ceram-
ide is a potential second messenger and regulates protein phos-
phorylations [27, 28]. It should be considered that in renal cells,
calcitriol acts on plasma membrane receptor and stimulates
SM-ceramide pathway that, in turn, may modulate, via protein
phosphorylations, the genomic response. Other rapid, non-genom-
ic effects of calcitriol include stimulation of Ca2 influx and a rise
in intracellular Ca21 levels [29]. These second messenger systems,
activated by lipophilic hormones, can both influence the genomic
response to the same hormones or modulate Na-Pi-COT via
non-genomic signaling pathways.
Finally, second messengers that activate protein kinases may
influence lipophilic hormone action by phosphorylating the cog-
nate receptor protein. For example, PKA-stimulating agents
promote phosphorylation of nuclear receptor for calcitriol, and
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Fig. 3. Hypothetical scheme of modulation of
Na-Pi-COT by the rate of GNG mediated via
cADPR and ca2 release. Ca2' released in
response to cADPR activates multifunctional
Ca2-CaM-dependent protein kinase II (Cal
CaM—PK-II). The kinase phosphorylates, mostly
threonine sites, in microtubule-associated
proteins (MAP2) and T protein. This
phosphoiylation promotes disassembly of
microtuboles and impedes the endocytotic
retrieval of Na-Pi-COT from BBM.
Abbreviations are: MA, metabolic acidosis;
LPD, Pi deprivation; DH, dehydrogenases;
cADPR-GH, cADPR glycohydrolase [41].
this phosphorylation is required for transcriptional activity of the
receptor [401. Thus, cAMP-PKA phosphorylation cascade and
possibly other protein kinases may regulate activity lipophilic
hormone at nuclear receptor level.
Intracrine regulation of Na-Pi-COT by metabolic factors
Multiple evidence points out that the rate of Na-Pi-COT in
BBM can be modulated in response to changes in intermediary
metabolism of the proximal tubule cell, usually changes in renal
gluconeogenesis [41]. The gluconeogenesis (GNG) is increased in
fasting, metabolic acidosis and in GCD surfeit when Na-P-COT is
inhibited, whereas GNG is decreased in Pi-depletion hyperinsu-
linemia or unilateral uretreal obstruction, when Na-Pi-COT is
increased [1, 41]. These observations and other accumulated data
led us to propose the hypothesis [42] proposing that NAD, an
abundant nucleotide involved in intermediary metabolic path-
ways, including GNG, serves as the intracellular signal regulating
Na-Pi-COT [reviewed in refs. 1, 41 and 431. In pharmacologic
doses injection of nicotinamide (NiAm) increases NAD in inverse
proportion to Na-P-COT [42]. Although experimental evidence
linking rate of ONG, NAD availability and/or content to changes
in rate of Na-Pi-COT is appreciable, it is only indirect, correlative,
and no mechanism was found by which NAD by itself would
interact with Na-Pi-COT within BBM [43].
We now propose a modified working hypothesis concerning
signaling pathway between GNG, NAD and Na-Pi-COT (Fig. 3),
and extend it to propose the signaling mechanisms by which
several intermediary metabolic pathways can modulate Na-Pi-
COT (Fig. 4). In recent years Lee and associates discovered [32,
33] that j3-NAD is enzymatically converted to a new and hitherto
unknown cyclic nueleotide, the cyclic ADP-ribose (cADPR) [re-
viewed in 32]. This regulatory system (Fig. 2) has been and
currently is studied mostly on the system of sea urchin homoge-
nates [32, 33, 44, 45]. At a very low (nM) concentrations cADPR
triggers release of Ca2 from intracellular endoplasmic reticulum
vesicular stores by interacting with ryanodine receptor-channel
(RYR), that is distinct from inositol-1 ,4,5-trisphosphate (1P3)-
receptor-channel for Ca2 [32]. The specificity of Ca21 release
through 1P3 receptor-channel, cADPR-controlled RYR channel,
and the most recently detected the nicotinic acid adenine dinu-
cleotide phosphate (NAADP) Ca2 release system [46, 47] is
demonstrated by action of specific inhibitors [32, 46], by homol-
ogous desensitization and lack of heterologous desensitization
[32, 44, 46, 71• ADP-ribose cyclase, a specific enzyme, catalyzes
conversion of 13-NAD to cADPR; in turn, cADPR is inactivated
by hydrolysis catalyzed by specific hydrolytic enzyme cADPR
glycohydrolase to non-cyclic ADP-ribose (ADPR), a nucleotide
which has no Ca2' -releasing activity (Fig. 2).
We suggest that 13-NAD, which is made available by increase of
GNG flux, regulates Na-Pi-COT by the following signaling mech-
anism. Increased J3-NAD leads to increased generation of
eADPR, which triggers release of Ca2 into cytoplasm in vicinity
of BBM (Fig. 3). Then increased Ca2, by activation of Ca2-
CaM protein kinase-Il, may regulate the cycling of Na-Pi-COT
from BBM into subapical cytoplasmie pooi and/or its reinsertion
into BBM (Fig. 3).
The notable feature of the proposed signaling pathway rests in
the fact that ADP-ribose cyclase needs not to be activated or
inhibited by hormones in the similar manner as adenylate cyclase.
In our recent studies on OK cells we found that the cells are
endowed with both ADP-ribose-eyelase and eADPR-glycohydro-
lase activities [48]. Importantly, the rate of eADPR generation is
proportional to the concentration of p-NAD substrate in the
range 0.2 to 0.8 mivi (Fig. 5), the values reported to be present in
Ca2 or
Ca2/CaM
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Fatty acid synthesis
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Fig. 4. Putative input of changes in intermediaiy
metabolism through mediation of cADPR and
NAADP, which release Ca2 from two distinct
Na intracellular stores, to regulate Na-Pi-COT.
cADPR acts on cADPR-binding protein
noncovalently associated with RYR, whereas
spermine and palmitoyl-CoA act directly on
RYR, and the released Ca2 enhances activity
of RYR by binding to RYR-associated
calmodulin (CaM). The Ca2 released from
stores controlled by cADPR, or stores
controlled by NAADP, modulates Na-P-COT
via activation of Ca2-dependent protein
kinases (such as protein kinase C), or Ca2/
CaM-dependent protein kinases and/or Ca2-
dependent protein phosphatases.
Boiled cells
(120 mm)
0 mm
ct-NAD
+
NAD (0.5 mM)
Fig. 5. Synthesis of cADPR by OK cells. Ca2 release from sea urchin egg
homogenate was monitored using fluo 3 as the Ca2' indicator. Permeabi-
lized OK cells were incubated with -NAD from various incubation
periods, as indicated, samples were added to sea urchin egg homogenate
bioassay and fluo 3 fluorescence was monitored. Also shown is the effect
of heat inactivation of OK cells and the replacement of p-NAD by
a-NAD on synthesis of cADPR by OK cells. Inset. Dependency of
cADPR synthesis on concentration of j3-NAD (from [481)
renal cortical tissue [49]. Therefore, the key point is that the
generation and cellular content of cADPR can be determined
simply by the supply of 13-NAD as a substrate, without changing
activity of ADPR-cyclase (Fig. 5). The increase or decrease of
content or availability of cellular p-NAD to ADP-ribose-cyclase,
in response to changes in the intermediary metabolism, can in
itself determine cADPR generation, Ca2 release via RYR and
other steps in the sequence (Figs. 3 and 4). The similar cADPR
system exists in LLC-PK1 cells (30, 31].
Besides GNG, other intermediary metabolic pathways and
factors may conceivably, via cADPR signaling, modulate Na-Pi-
COT: fatty acid coenzyme A [45], polyamines and Mg2 [44].
Spermine and related polyamines inhibit stimulation of Ca2
release through RYR by cADPR [44], and Mg2 shows a similar
inhibitory effect [45]. On the other hand, palmitoyl-CoA and
acyl-CoA of some other fatty acids of similar length (C14 - C18)
by itself triggers Ca2 release through RYR [45] and also
potentiates the cADPR-triggered Ca21 release [45]. Thus, even
without a change in steady state of cADPR, changes in fatty acid
metabolism and availability of palmitoyl CoA can have a powerful
positive input upon RYR and cADPR signaling pathway [45].
The -NAD—cADPR—Ca2 signaling system can be, as men-
tioned in the above, stimulated by atRA as a first messenger,
which is the first extracellular hormone shown to have such effect
[31]. Stimulatory effect atRA upon ADP-ribose cyclase in LLC-
PK1 cells is very selective: T3, calcitriol, cAMP, cGMP and
forskolin had no effect (Beers, Dousa, unpublished results). Thus,
atRA action by increasing ADP-ribose cyclase [31] may up-
regulate the f3-NAD—cADPR—Ca2 pathway. Conversely, as
mentioned in the above, the cADPR-triggered release of Ca2
may conceivably modulate transcriptional activation by acting on
CREB [39].
Most recently, we identified nicotinic acid adenine dinucleotide
phosphate (NAADP) as a factor (Fig. 6) that releases Ca2 in nM
concentrations from its intracellular stores via a mechanism that is
different from Ca2 release both by cADPR or by 1P3 [46, 47].
Furthermore, NAADP probably triggers the release of Ca2 from
intracellular stores that are distinct from the stores containing
cADPR-controlled and 1P3-controlled receptor-channels for Ca2
release [50]. NAADP (Fig. 6) can be generated enzymatically in
rat tissues from NADP catalyzed by the transglycosidase activity
of NAD-glycohydrolase, an enzyme activity that catalyzes ex-
change nicotinamide for nicotinic acid [47], but possibly also by
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Fig. 6. Structure of nicotinic acid adenine dinucleotide phosphate (NAAD),
a Ca2 t.releasing nucleotide [46].
It can be predicted that released Ca2 acts mainly by stimulating
Ca2tdependent protein kinases or phosphatases involved in
regulation of Na-Pi-COT, for example, by modulating cytoskeletal
elements operant in insertion and/or retrieval of Na-Pi-COT from
BBM (Fig, 3).
In conclusion, several novel signaling mechanisms were identi-
fied in non-renal and some even in renal cells, which may have
specific roles in regulation of Na-Pi-COT by lipophilic hormones
and intermediary metabolic factors. A formidable task lies ahead
to delineate which of these signaling mechanisms are present in
renal cells cotransporting Na and Pi and thus have physiologic
importance.
Acknowledgments
The studies from the author's laboratory were supported by NIH grant
DK-30579 from NIDDK, and by the Mayo Foundation. Ms. Mary E.
Bennett provided secretarial assistance.
Reprint requests to Thomas P. Dousa, M.D., Ph.D., 921B Guggenheim
Bldg., Mayo Clinic, Rochester, Minnesota 55905 USA.
Appendix
I.ess common abbreviations are: Na-Pi-COT, Na-Pi cotransport (or
cotransporter); BBM, brush border membrane; TPTX, thyroparathyroid-
ectomy; GCD, glucocorticoid(s); T3, 3,3,5'-triiodothyronin; atRA, all-
trans-retinoic acid; E2, (3-estradiol; PFA, phosphonoformie acid; RYR,
ryanodine receptor-calcium channel; NAADP, nicotinic acid adenosine
dinucleotide phosphate; cADPR, cyclic ADP-ribose.
"Lipophilie hormones" is a working term encompassing hormones
which are small size (< 1 kDa) lipophilie molecules, bound tightly to their
respective plasma carrier proteins and act via "nuclear" mechanism. These
include both steroid derivatives and non-steroid compounds. This defini-
tion does not include lipophilic regulating agents such as prostanoids.
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